. Previous studies of the growth-promoting effects of cobalamins and other substances for Euglena gracilis, summarized by Smith (1965) , preceded the discovery of the roles of methylcobalamin and coenzyme B12 in human metabolism (Toohey and Barker, 1961; Lindstrand and Stahlberg, 1963; StAhlberg, Radner, and Norden, 1967), and as the activity of these cobalamins and certain analogues for Euglena gracilis Z strain had not been studied, it seemed desirable to do so.
The measurement of the 'vitamin P1' concentration in tissues by microbiological assay using Euglena gracilis is a widely used procedure. Euglena gracilis variant bacillaris was used by Hutner, Provasoli, Stokstad, Hoffman, Belt, Franklin, and Jukes (1949) and by Ross (1950 and 1952) who described techniques applicable to clinical material and the Z strain was used by Hutner, Bach, and Ross (1956) . Previous studies of the growth-promoting effects of cobalamins and other substances for Euglena gracilis, summarized by Smith (1965) , preceded the discovery of the roles of methylcobalamin and coenzyme B12 in human metabolism (Toohey and Barker, 1961; Lindstrand and Stahlberg, 1963;  StAhlberg, Radner, and Norden, 1967) , and as the activity of these cobalamins and certain analogues for Euglena gracilis Z strain had not been studied, it seemed desirable to do so.
Materials and Methods
In all studies the assay methodology was essentially that of Hutner et al (1956) Solutions of cyanocobalamin, hydroxocobalamin, coenzyme B12, methylcobalamin, sulphitocobalamin, nitritocobalamin, factor B, and the 'red acids'-the monocarboxylic acid of cyanocobalamin, the monocarboxylic acid of hydroxocobalamin, and the dicarboxylic acid of cyanocobalamin-were made available in known concentration by Dr L. Mervyn of Glaxo Ltd. Various batches of cyanocobalamin, hydroxocobalamin, methylcobalamin, and coenzyme B12 were used, the concentrations being confirmed by absorption spectrometry with a Unicam SP 800 spectrophotometer. Unless otherwise stated, solutions were stored at +4°C and all manipulations except those immediately preceding microbiological assay were carried out in a dim red light.
Initially all samples were assayed on at least three occasions in final concentrations of 1 25, 2 5, 5, 10, 15, 25, and 50 ,u,g/ml and the values compared to those obtained with cyanocobalamin at the same final concentrations. In view of the results further studies were undertaken as follows: (1) the effect of increasing concentrations of factor B and the 'red acids'; (2) repeated assays of aqueous solutions of coenzyme B12 and methylcobalamin in concentrations of 750 ,u,ug/ml and 375 ,u,ug/ml; and (3) repeated assays of cyanocobalamin, hydroxocobalamin, methylcobalamin, and coenzyme B12 in aqueous solution and bound to pools of serum and human liver homogenate. For the last-named study materials were prepared in a dim red light at 17°C by adding 4,000 ,u,ug cobalamin in 1 ml Water (9 ml) + water (I ml) 2-5 Water (9 ml) + cyanocobalamin (1 ml -4,000 ggg) 458 (62 5) Water (9 ml) + hydroxocobalamin (1 ml -4,000 jugg) 392 (65 5) Water (9 ml) + methylcobalamin (1 ml -4,000 jusg) 293 (66 2) Water (9 ml) + coenzyme Bl,
(1 ml -4,000 sjug) 313 (47-4) Pool serum (9 ml) Pool serum + water (1 ml)
357 (64 0 -5, 5, 10, 15, 20, 25. 30, 35, 40, 45, 50, and 60 ,u,ug/ml Factor B and the red acids were inactive at low concentrations. At a concentration of 10,000,ug/ml factor B had an activity equal to cyanocobalamin 10 ,Lu,g/ml and the monocarboxylic acid of cyanocobalamin at 100,000 p,ug/ml was as active as cyanocobalamin 50 ,u,tg/ml. The monocarboxylic acid of hydroxocobalamin and the dicarboxylic acid of cyanocobalamin were inactive at concentrations up to and including 200,000 ,u,Lg/ml.
An aqueous solution of coenzyme B12 750 p,g/ml assayed on six occasions gave a mean value of 483 ,u,ug/ml (standard deviation 81-4) as expressed from the cyanocobalamin standards and a solution of 375 ,ug/ml a value of 256 j,u,g/ml (standard deviation 65 0) the relative activities being 64 % and 68 %. Similarly, six assays of methylcobalamin 750 ,u,ug/ml gave a mean value of 544 ,u,ug/ml (standard deviation 123) an activity of 72% and methylcobalamin 375 i.qig/ml a mean value of 232 ,u,ug/ml (standard deviation 96) an activity of 62%.
The results for eight assays of cyanocobalamin, hydroxocobalamin, methylcobalamin, and coenzyme B12 in aqueous solution and bound to pooled tissues are summarized in Table I . Analysis of the results by the Wilcoxon test (2 tail) showed significant differences in the results from aqueous solutions of cyanocobalamin and coenzyme B12 (P < 001), cyanocobalamin and methylcobalamin (p < 0 01), hydroxocobalamin and coenzyme B12 (P < 001), hydroxocobalamin and methylcobalamin (p < 0X01), and in the results from serum-bound hydroxocobalamin and serum-bound coenzyme B12 (P < 002).
Activities of various cobalamins for Euglena gracilis with reference to vitamin B12 assay with Euglena Discussion
The most interesting results are those relating to the 'physiological cobalamins'-coenzyme B12, methylcobalamin, hydroxocobalamin, andcyanocobalamin. Photolysis of coenzyme B12 and methylcobalamin leads to the formation of hydroxocobalamin which was found by Robbins, Hervey, and Stebbins (1950) to be as active as cyanocobalamin for Euglena gracilis var. bacillaris and confirmed for the Z strain in this study. The results of assays of several batches of coenzyme B12 and methylcobalamin of known, that is spectrophotometric concentration, were therefore unexpected. Further enquiries were indicated because these results raised the suspicion that values obtained by Euglena assay of tissues were underestimates. Because of the considerable interassay variation (see Ross, Hutner, and Bach, 1957; Anderson, 1964) repetitive assays were necessary. The results formalized statistically the previous finding that coenzyme B12 and methylcobalamin in water have an activity which is significantly inferior to similar concentrations of cyanocobalamin and hydroxocobalamin. In addition it is clear that this inferiority is abolished when the cobalamins are bound to serum or liver homogenate, the sole exception being serum-bound coenzyme and serum-bound hydroxocobalamin. Any explanation of the results must take into account the fact that hydroxocobalamin is a product of photolysis of coenzyme B12 and methylcobalamin, and this suggests that other products of photolysis act as inhibitors to the growth of Euglena unless tissues are also present. Treatment of coenzyme B12 in water with potassium cyanide, before and after photolysis, by prolonged photolysis in aerobic conditions, and by autoclaving at 15 lb for up to 30 minutes did not affect the activity, and attempts at isolating an inhibitor from solutions of photolysed coenzyme B12 were unsuccessful.
From the practical aspect it is clear that quantitation of solutions of coenzyme B12 and methylcobalamin in water by Euglena assay using cyanocobalamin or hydroxocobalamin standards will result in a significant underestimate of the true concentration. The absence of significant differences, with one exception, between cobalamins bound to serum or liver homogenate does not necessarily mean, however, that quantitation of serum or liver-bound coenzyme B12 and methylcobalamin can be achieved with cyanocobalamin or hydroxocobalamin standards. Taking the mean values for cyanocobalamin or hydroxocobalamin, pool serum, and pool liver homogenate (Table I) There is no evidence that nitritocobalamin, factor B, and the three 'red acids' tested play a part in vitamin B12 metabolism in man and the results are of little practical interest. We ascribe the trivial activities of the red acids and factor B as due to traces of cyanocobalamin and the results for factor B accord with those found by Coates and Kon (1957) using Euglena gracilis var. bacillaris. It seems inherently more likely that the lack of B activity of factor B and the 'red acids' tested is due to considerable differences in structure than to the presence of inhibitors.
